Samer Samir Morcos Ebaid

Samer Ebaid practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Samer Ebaid's NPI, 1043648355, was assigned on October 23, 2013. Samer Ebaid graduated from Kasr El Aini Cairo Fom in 2011. Samer Ebaid holds California license A136332.

Samer Ebaid's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Samer Ebaid's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Samer Ebaid is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Samer Ebaid to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Samer Ebaid practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Samer Ebaid's primary specialty in the NPI Registry, under taxonomy code 208600000X. Samer Ebaid is board certified in surgery by the American Board of Surgery. Dmand AI has Samer Ebaid's licenses on file in 4 states: California, Ohio, Florida and New York.

Dmand AI lists gallbladder removal among the conditions Samer Ebaid treats.

CMS data shows 934 Medicare services from Samer Ebaid across 4 procedure codes in 2024, for 153 Medicare patients. Medicare paid $97,415 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 153 Medicare patients who saw Samer Ebaid in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 67% are also on Medicaid. Their average risk score is 4.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Samer Ebaid's median patient age at 55, with 44% women.

In 2020, Samer Ebaid wrote 58 Medicare Part D claims. They cover 4 drugs, with $5,194 in total drug cost. In 2019, CMS named 258 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Samer Ebaid for performance year 2024, reported as part of a group. Samer Ebaid accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Samer Ebaid, published from 2019 to 2025. 2025 was the busiest year, with 2. Samer Ebaid's most frequent co-authors are Vatche Garen Agopian, MD, Fady Michael Kaldas, MD and Douglas G. Farmer, MD.

CMS Open Payments shows 18 general payments to Samer Ebaid from 7 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 92% of the total. TransMedics, Inc. paid the most, $5,072.

Dmand AI lists 1 award for Samer Ebaid.

Samer Ebaid graduated from Kasr El Aini Cairo Fom in 2011. Samer Ebaid is a member of ACS.

Samer Ebaid is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.